Table 1.
Protein Change | Pfam Domain [8] | Tumor Type | Impact | HER2 | Phosphorylation | Reference |
---|---|---|---|---|---|---|
L12R | - | Breast Cancer | ND | Negative | ND * | [35] |
A20T | Lung cancer | ND | ND | ND | [24] | |
L49H | Lung cancer | ND | Negative | ND | [21] | |
L49H | Glioblastoma | ND | ND | ND | [20] | |
E139D | Receptor L | Breast Cancer | ND | Negative | ND | [35] |
E139G | Breast Cancer | ND | Negative | ND | [35] | |
R157W | Bladder cancer (MPUC) | ND | Negative | ND | [32] | |
T216S | Furin-like | Lung cancer | ND | Negative | ND | [21] |
T216S | Glioblastoma | ND | ND | High | [20] | |
I263T | Colorectal cancer | ND | Negative | ND | [36] | |
G309A | Breast Cancer | Activating | Negative | ND | [27] | |
G309E | Breast Cancer | Activating | Positive | ND | [24] | |
S310F | Gastric cancer | Activating | ND | High | [38] | |
S310F(2) | Breast Cancer | Negative | High | [26] | ||
S310F | Lung cancer | Negative | High | [20] | ||
S310F | Breast Cancer | Negative | High | [25] | ||
S310F(2) | Colorectal cancer | Negative | High | [37] | ||
S310F | Breast Cancer | Negative | High | [28] | ||
S310F | Lung cancer | Positive | High | [22] | ||
S310F | Breast Cancer | Negative | High | [29] | ||
S310F(4) | Bladder cancer (MPUC) | Negative | High | [32] | ||
S310F | Adnexal cancer | Negative | High | [33] | ||
S310F | Breast Cancer | Negative | High | [29] | ||
S310F(2) | Breast Cancer | Positive | High | [30] | ||
S310F | Lung cancer | ND | High | [23] | ||
S310F | Breast Cancer | Negative | High | [31] | ||
S310F(4) | Breast Cancer | Positive | ND | [35] | ||
S310Y | Lung cancer | Activating | ND | High | [24] | |
S310Y | Lung cancer | ND | High | [20] | ||
S310Y | Colorectal cancer | Positive | High | [21] | ||
S310Y | Bladder cancer (MPUC) | Negative | High | [20] | ||
C311R and E321G | Lung cancer | ND | Negative | ND | [21] | |
C311R | Glioblastoma | ND | ND | Low | [20] | |
N319D | Lung cancer | ND | Negative | ND | [21] | |
N319D | Glioblastoma | ND | ND | ND | [20] | |
E321G | Glioblastoma | ND | ND | Low | [20] | |
D326G and C334S | Lung cancer | ND | Negative | ND | [21] | |
D326G | Glioblastoma | ND | ND | Low | [20] | |
C334S | Glioblastoma | ND | ND | ND | [20] | |
A466T | Receptor L | Colorectal cancer | ND | Negative | ND | [36] |
A466V | Breast Cancer | Activating | Negative | High | [35] | |
C515R | Growth factor receptor | Breast Cancer | Activating | Negative | High | [35] |
T526A | Breast Cancer | Activating | Negative | High | [35] |
* ND = no data available.